|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
in00002531122 |
005 |
20211202192506.0 |
006 |
m d f |
007 |
cr an||||||||| |
008 |
091119s1999 mdu s f000 0 eng d |
035 |
|
|
|a (OCoLC)ocn467324210
|
040 |
|
|
|a GPO
|c GPO
|d GPO
|d MvI
|d UtOrBLW
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a WWW
|
074 |
|
|
|a 0499-T (online)
|
086 |
0 |
|
|a HE 20.4702:R 26/8
|z HE 20.4702:R 26
|
245 |
0 |
0 |
|a Guidance for industry :
|b providing regulatory submissions in electronic format, general considerations.
|
246 |
3 |
0 |
|a Providing regulatory submissions in electronic format, general considerations
|
264 |
|
1 |
|a Rockville, MD :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :
|b Center for Biologics Evaluation and Research,
|c [1999]
|
300 |
|
|
|a 1 online resource (17 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a "IT 2."
|
500 |
|
|
|a "January 1999."
|
500 |
|
|
|a Electronic resource.
|
650 |
|
0 |
|a Electronic filing systems
|x Government policy
|z United States.
|
650 |
|
0 |
|a Drug approval
|z United States.
|
710 |
2 |
|
|a Center for Drug Evaluation and Research (U.S.)
|
710 |
2 |
|
|a Center for Biologics Evaluation and Research (U.S.)
|
856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS116750
|t 0
|
999 |
|
|
|a MARS
|
999 |
f |
f |
|s 5b0200d6-043f-3d6f-ab13-e62d21632091
|i 0e8b3e4d-b168-3f27-8ff5-6eb146c55305
|t 0
|
952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4702:R 26
|h Superintendent of Documents classification
|
998 |
f |
f |
|a HE 20.4702:R 26
|t 0
|l Available Online
|